For the Inventor, By the Inventor

Enter assignee name

Menlo Park, CA, United States of America

Dermira, Inc.

USPTO Granted Patents = 16

% Expired Patents = 18.8

CIPO Patents = 1

EPO Patents = 7

Trademarks = 1

Forward Citations = 56

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Anthony Adrian Shaw (14 out of 20 patents)

Patricia Andres (8 out of 41 patents)

John Allan Statler (8 out of 11 patents)

4. Delphine Caroline Imbert (8 out of 15 patents)

5. Jennifer Leigh Nelson (8 out of 23 patents)

6. Lisa Lynn McQueen (8 out of 15 patents)

7. Stephan Xander Mattheus Boerrigter (8 out of 12 patents)

8. Mark Andres (6 out of 25 patents)

9. Jon Gordon Selbo (6 out of 12 patents)

10. Kanjai Khumtaveeporn (3 out of 4 patents)

11. Pavel Krasik (3 out of 4 patents)

12. Enrico Vigano (2 out of 3 patents)

13. Renato Molteni (2 out of 3 patents)

14. Laura Gleave (2 out of 2 patents)

15. Ferda Cevikbas (2 out of 2 patents)

16 patents: Sort by Forward Citations

1. 12728117 - MrgprX2 antagonists for the treatment of inflammatory disorders (2026-09-08),

2. 12502380 - MrgprX2 antagonists for the treatment of inflammatory disorders (2025-12-23),

3. 10906871 - Processes for making, and methods of using, glycopyrronium compounds (2021-02-02),

4. 10548875 - Glycopyrrolate salts (2020-02-04),

5. 10543192 - Glycopyrrolate salts (2020-01-28),

6. 10294201 - Process for production of glycopyrronium tosylate (2019-05-21),

7. 10004717 - Glycopyrrolate salts (2018-06-26),

8. 9975867 - Synthetic process for preparing 2-furoic acid derivatives (2018-05-22),

9. 9926270 - Process for production of glycopyrronium tosylate (2018-03-27),

10. 9745277 - Synthetic process for preparing 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylate (2017-08-29),

11. 9610278 - Glycopyrrolate salts (2017-04-04),

12. 9487497 - Synthetic process for preparing 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylate (2016-11-08),

13. 9259414 - Glycopyrrolate salts (2016-02-16),

14. 9006462 - Glycopyrrolate salts (2015-04-14),

15. 9006461 - Crystalline glycopyrrolate tosylate (2015-04-14),

Dermira, Inc. is a biopharmaceutical company based in Menlo Park, California, focused on developing innovative therapies for dermatological conditions. The company specializes in addressing unmet medical needs in skin diseases, leveraging advanced research and technology to create effective treatments. Dermira's commitment to improving patient outcomes drives its research initiatives, which encompass a range of therapeutic areas within dermatology, aiming to enhance the quality of life for individuals suffering from various skin disorders.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

16 Patents

#90 in Menlo Park, CA

#4,767 in California

#19,898 in US

#37,766 in the World

Menlo Park, CA, United States of America

Dermira, Inc.

Forward Citations = 56

19 inventors:

Anthony Adrian Shaw (14 out of 20 patents)

Patricia Andres (8 out of 41 patents)

John Allan Statler (8 out of 11 patents)

4. Delphine Caroline Imbert (8 out of 15 patents)

5. Jennifer Leigh Nelson (8 out of 23 patents)

Please report any incorrect information to [email protected]

Loading…